Salarius Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
70.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.55
|
-6.41
|
-3.86
|
-151.37%
|
|
2022-06-30
|
-2.62
|
-2.25
|
0.37
|
14.12%
|
|
2022-03-31
|
-2.25
|
-3.25
|
-1.00
|
-44.44%
|
|
2021-12-31
|
-2.12
|
-2.25
|
-0.13
|
-6.13%
|
|
2021-09-30
|
-1.62
|
-2.00
|
-0.38
|
-23.46%
|
|
2021-06-30
|
-1.42
|
-1.75
|
-0.33
|
-23.24%
|
|
2021-03-31
|
-1.37
|
-1.50
|
-0.13
|
-9.49%
|
|
2020-12-31
|
-2.75
|
-2.50
|
0.25
|
9.09%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-11.91
|
|
2021-12-31
|
-7.50
|
|
2020-12-31
|
-5.35
|
|
2019-12-31
|
-5.81
|
|
2018-12-31
|
-30.50
|
|
2017-12-31
|
-50.00
|
|
2016-12-31
|
-2.45
|
|
2015-12-31
|
-2.10
|
|
2014-12-31
|
-1.82
|